Massachusetts Financial Services CO Exact Sciences Corp Transaction History

Massachusetts Financial Services CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$56.04 - $82.66 $6.37 Million - $9.4 Million	-113,758 Closed	0 $0
Q3 2018 Oct 25, 2018	SELL	$48.29 - $80.6 $2.59 Million - $4.33 Million	-53,690 Reduced 32.06%	113,758 $8.98 Million
Q2 2018 Jul 30, 2018	SELL	$37.84 - $69.96 $176,485 - $326,293	-4,664 Reduced 2.71%	167,448 $10 Million
Q1 2018 May 04, 2018	SELL	$39.82 - $57.53 $127,543 - $184,268	-3,203 Reduced 1.83%	172,112 $6.94 Million
Q4 2017 Feb 14, 2018	SELL	$46.49 - $60.51 $1.96 Million - $2.56 Million	-42,252 Reduced 19.42%	175,315 $9.21 Million

Q3 2017 Nov 14, 2017	SELL	$37.05 - $47.12 $1.71 Million - $2.17 Million	-46,128 Reduced 17.49%	217,567 $10.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	263,695	263,695 $9.33 Million

699

160M

5.84M

2.58M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $7.64B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

Stay updated on Massachusetts Financial Services CO with notifications on news.